3.2(top 10%)
impact factor
306(top 50%)
papers
3.7K(top 20%)
citations
26(top 20%)
h-index
3.5(top 10%)
impact factor
403
all documents
4.3K
doc citations
54(top 20%)
g-index

Top Articles

#TitleJournalYearCitations
1Carbapenem resistance: overview of the problem and future perspectivesTherapeutic Advances in Infectious Disease2016397
2The role of nanotechnology in the treatment of viral infectionsTherapeutic Advances in Infectious Disease2017233
3Recent advances in the understanding of antibiotic resistance in Clostridium difficile infectionTherapeutic Advances in Infectious Disease2016212
4Extrahepatic manifestations of chronic hepatitis C virus infectionTherapeutic Advances in Infectious Disease2016176
5Blastocystis, an unrecognized parasite: an overview of pathogenesis and diagnosisTherapeutic Advances in Infectious Disease2013154
6The global problem of childhood diarrhoeal diseases: emerging strategies in prevention and managementTherapeutic Advances in Infectious Disease2018132
7The role of the healthcare environment in the spread of multidrug-resistant organisms: update on current best practices for containmentTherapeutic Advances in Infectious Disease2014103
8Recent developments and future prospects in the treatment of visceral leishmaniasisTherapeutic Advances in Infectious Disease201699
9Extrapulmonary tuberculosis: are statistical reports accurate?Therapeutic Advances in Infectious Disease201495
10COVID-19 and post-infectious myalgic encephalomyelitis/chronic fatigue syndrome: a narrative reviewTherapeutic Advances in Infectious Disease202185
11The emerging SARS-CoV-2 variants of concernTherapeutic Advances in Infectious Disease202182
12Azithromycin, cardiovascular risks, QTc interval prolongation, torsade de pointes, and regulatory issues: A narrative review based on the study of case reportsTherapeutic Advances in Infectious Disease201375
13Management of community-acquired pneumonia in older adultsTherapeutic Advances in Infectious Disease201468
14Hepatitis E: an underestimated emerging threatTherapeutic Advances in Infectious Disease201966
15Respiratory syncytial virus: diagnosis, prevention and managementTherapeutic Advances in Infectious Disease201965
16The host immune response to Clostridium difficile infectionTherapeutic Advances in Infectious Disease201353
17Clinical management of infections caused by multidrug-resistant EnterobacteriaceaeTherapeutic Advances in Infectious Disease201350
18Management of acute bacterial skin and skin structure infections with a focus on patients at high risk of treatment failureTherapeutic Advances in Infectious Disease201750
19Antimicrobial effects of lysophosphatidylcholine on methicillin-resistant Staphylococcus aureusTherapeutic Advances in Infectious Disease201750
20Best practice in the prevention and management of paediatric respiratory syncytial virus infectionTherapeutic Advances in Infectious Disease201649
21Invasive fungal infections in transplant recipientsTherapeutic Advances in Infectious Disease201345
22Climate change and antibiotic resistance: a deadly combinationTherapeutic Advances in Infectious Disease202140
23COVID-19 associated mucormycosis: the urgent need to reconsider the indiscriminate use of immunosuppressive drugsTherapeutic Advances in Infectious Disease202136
24COVID-19 vaccine hesitancy among staff and students in a Nigerian tertiary educational institutionTherapeutic Advances in Infectious Disease202136
25Viral infections and the development of asthma in childrenTherapeutic Advances in Infectious Disease201335
26COVID-19 vaccine acceptance among high-risk populations in UgandaTherapeutic Advances in Infectious Disease202133
27Risk factors and outcomes for multidrug-resistant Gram-negative bacilli bacteremiaTherapeutic Advances in Infectious Disease201832
28Management of febrile neutropenia in the era of bacterial resistanceTherapeutic Advances in Infectious Disease201330
29The implications of whole-genome sequencing in the control of tuberculosisTherapeutic Advances in Infectious Disease201628
30Infectious complications of CAR T-cell therapy: a clinical updateTherapeutic Advances in Infectious Disease202128
31Urogenital tuberculosis: definition and classificationTherapeutic Advances in Infectious Disease201426
32Advances in hepatitis B therapeuticsTherapeutic Advances in Infectious Disease202026
33Monkeypox – a description of the clinical progression of skin lesions: a case report from Colorado, USATherapeutic Advances in Infectious Disease202226
34How to manage KPC infectionsTherapeutic Advances in Infectious Disease202025
35Optimal treatment of HIV-associated neurocognitive disorders: myths and reality. A critical reviewTherapeutic Advances in Infectious Disease201924
36Community-acquired pneumonia: identification and evaluation of nonrespondersTherapeutic Advances in Infectious Disease201323
37Adjunctive ceftaroline in combination with daptomycin or vancomycin for complicated methicillin-resistant Staphylococcus aureus bacteremia after monotherapy failureTherapeutic Advances in Infectious Disease201923
38Symptom cluster analysis of long COVID-19 in patients discharged from the Temporary COVID-19 Hospital in Mexico CityTherapeutic Advances in Infectious Disease202223
39Current tools available for the diagnosis of drug-resistant tuberculosisTherapeutic Advances in Infectious Disease201622
40Oral mucositis caused by Candida glabrata biofilms: failure of the concomitant use of fluconazole and ascorbic acidTherapeutic Advances in Infectious Disease201722
41Bacterial co-infections and antibiotic prescribing practice in adults with COVID-19: experience from a single hospital clusterTherapeutic Advances in Infectious Disease202022
42Relevance of liver failure for anti-infective agents: from pharmacokinetic alterations to dosage adjustmentsTherapeutic Advances in Infectious Disease201421
43Visceral scalloping on abdominal computed tomography due to abdominal tuberculosisTherapeutic Advances in Infectious Disease201721
44Antimicrobial stewardship and antibiograms: importance of moving beyond traditional antibiogramsTherapeutic Advances in Infectious Disease202121
45Plazomicin: a new aminoglycoside in the fight against antimicrobial resistanceTherapeutic Advances in Infectious Disease202020
46Risk of infection associated with targeted therapies for solid organ and hematological malignanciesTherapeutic Advances in Infectious Disease202120
47SARS-CoV-2 RNA in the Cerebrospinal Fluid of a Patient with Long COVIDTherapeutic Advances in Infectious Disease202120
48Telavancin: a novel semisynthetic lipoglycopeptide agent to counter the challenge of resistant Gram-positive pathogensTherapeutic Advances in Infectious Disease201719
49Utility of tissue Xpert-Mtb/Rif for the diagnosis of intestinal tuberculosis in patients with ileocolonic ulcersTherapeutic Advances in Infectious Disease201918
50Antiretroviral adherence for adolescents growing up with HIV: understanding real life, drug delivery and forgivenessTherapeutic Advances in Infectious Disease202018